Andy Lee is Senior Vice President and Head, Global Clinical Trial Operations (GCTO). In this role, Andy leads and manages GCTO, with particular focus on global, in-patient clinical trials, designed and executed to meet cost, speed and quality standards. Andy is also responsible for the design and study/data management of clinical protocols in all regions and countries, as well as the tools, systems and processes to conduct Merck clinical trials.
Andy joined Merck in September 2014 from Sanofi, where he served as Senior Vice President and Deputy Head of Clinical Sciences and Operations (CSO) and Head of the CSO Clinical Operations. In addition to directing CSO, Andy led the integration of Sanofi with Genzyme, where he was Senior Vice President, Global Clinical Operations responsible for Clinical Trials and Clinical Supplies. Earlier in his career, he spent more than 17 years in a range of positions of increasing responsibility at Pfizer.
Andy holds leadership positions in a number of professional societies, including the role of Treasurer of TransCelerate Biopharma, Inc., a non-profit organization that comprises the world’s leading pharmaceutical and biotech companies. He also serves as a member of the TransCelerate Operating Committee. Andy received his Masters in Bioenergetics and Physiology from Ball State University in Indiana and two undergraduate degrees from Rhodes University in South Africa.